BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 9573043)

  • 1. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
    Bucay N; Sarosi I; Dunstan CR; Morony S; Tarpley J; Capparelli C; Scully S; Tan HL; Xu W; Lacey DL; Boyle WJ; Simonet WS
    Genes Dev; 1998 May; 12(9):1260-8. PubMed ID: 9573043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.
    Min H; Morony S; Sarosi I; Dunstan CR; Capparelli C; Scully S; Van G; Kaufman S; Kostenuik PJ; Lacey DL; Boyle WJ; Simonet WS
    J Exp Med; 2000 Aug; 192(4):463-74. PubMed ID: 10952716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.
    Schoppet M; Preissner KT; Hofbauer LC
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):549-53. PubMed ID: 11950689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
    Mizuno A; Amizuka N; Irie K; Murakami A; Fujise N; Kanno T; Sato Y; Nakagawa N; Yasuda H; Mochizuki S; Gomibuchi T; Yano K; Shima N; Washida N; Tsuda E; Morinaga T; Higashio K; Ozawa H
    Biochem Biophys Res Commun; 1998 Jun; 247(3):610-5. PubMed ID: 9647741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
    Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P
    Circ Res; 2004 Nov; 95(11):1046-57. PubMed ID: 15564564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
    Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.
    Chagraoui H; Tulliez M; Smayra T; Komura E; Giraudier S; Yun T; Lassau N; Vainchenker W; Wendling F
    Blood; 2003 Apr; 101(8):2983-9. PubMed ID: 12506018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
    Bennett BJ; Scatena M; Kirk EA; Rattazzi M; Varon RM; Averill M; Schwartz SM; Giachelli CM; Rosenfeld ME
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2117-24. PubMed ID: 16840715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women.
    Brändström H; Gerdhem P; Stiger F; Obrant KJ; Melhus H; Ljunggren O; Kindmark A; Akesson K
    Calcif Tissue Int; 2004 Jan; 74(1):18-24. PubMed ID: 14508625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
    Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
    Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
    Yamazaki H; Sasaki T
    J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin: a link between osteoporosis and arterial calcification?
    Hofbauer LC; Schoppet M
    Lancet; 2001 Jul; 358(9278):257-9. PubMed ID: 11498208
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.
    Price PA; June HH; Buckley JR; Williamson MK
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1610-6. PubMed ID: 11597934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function.
    Yun TJ; Tallquist MD; Aicher A; Rafferty KL; Marshall AJ; Moon JJ; Ewings ME; Mohaupt M; Herring SW; Clark EA
    J Immunol; 2001 Feb; 166(3):1482-91. PubMed ID: 11160187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.
    Rhee EJ; Oh KW; Jung CH; Lee WY; Oh ES; Yun EJ; Baek KH; Kang MI; Kim SW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):689-97. PubMed ID: 16712673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
    Salmon P
    J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
    Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.
    Zehnder AF; Kristiansen AG; Adams JC; Kujawa SG; Merchant SN; McKenna MJ
    Laryngoscope; 2006 Feb; 116(2):201-6. PubMed ID: 16467704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.